obesity glp-1 news today health pharma drugs october 2025 Outlook for obesity in 2025: more Live today at @pix11news talking

Novo Nordisk also plans to introduce two new, lower-priced brand-name products in Canada: Plosbrio and Poviztra as chemically identical alternatives to Ozempic and Wegovy, respectively

Protein Is No Longer Optional As appetite decreases, many people eat less of everythingincluding protein

Companies that have built pipeline succession years in advance are prepared for them

Pea protein, rich in essential amino acids and highly digestible, has been shown to boost GLP-1 secretion, reduce hunger hormones like ghrelin, and promote prolonged feelings of fullness

A study published in the Endocrine Journal studied data from more than 12,000 patients who used semaglutide to treat their diabetes

Monitoring report: GLP-1 RA prescribing trends-March 2024 data